EVIDENCE PROFILE / PUBLISHED
MOTS-c
MOTS-c is described as a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA region. The reviewed sources did not identify a completed human administration study establishing safety or benefit.
Evidence at a glance
- Human
- Not rated
- Animal/cell
- Not rated
- Approved medicine
- None foundScope: the sources reviewed.
Summarises how much research the profile's sources report, and of what kind. It is not a verdict on the compound or on any catalogue material.
PREPPY BOY ASKS
“A familiar name can hide a different molecule, fragment, formulation, or evidence story.”
The catalogue name is a starting point, not proof of formulation or identity. Cell and animal work links it to metabolic stress responses, AMPK-related signaling, and insulin-sensitivity models.
Identity
MOTS-c is described as a 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA region.
Biological mechanism or research interest
Cell and animal work links it to metabolic stress responses, AMPK-related signaling, and insulin-sensitivity models.
Verified approved human uses
No approved human use was verified in the sources reviewed; FDA reports that it identified no human exposure data for nominated compounded MOTS-c.
Investigational human evidence
The reviewed sources did not identify a completed human administration study establishing safety or benefit.
Popular claims versus demonstrated findings
Exercise-mimetic, fat-loss, glucose-control, and longevity claims are not demonstrated human outcomes.
Human versus animal or cell evidence
The foundational paper reports cell experiments and mouse metabolic models; those results remain preclinical.
Limitations and known risks
Human pharmacokinetics, dose-response, immunogenicity, impurities, and route-specific safety are unknown.
